Pfizer Cancer Drug Xalkori Shows Positive Results as First-Line Remedy

Pfizer said its Xalkori cancer drug was superior to chemotherapy as a first-line treatment for a certain type of advanced non-squamous non-small cell lung cancer in a recent Phase III study.



from WSJ.com: US Business http://ift.tt/1jBX0SG

via IFTTT